Different roles of the IGF-I Ec peptide (MGF) and mature IGF-I in myoblast proliferation and differentiation.
Yang. Shi Yu SY; Goldspink. Geoffrey G
Key Findings
- MGF’s E‑domain boosts myoblast (muscle precursor) proliferation
- MGF’s E‑domain blocks the final step of muscle cell differentiation
- The effect is mediated by a receptor other than the classic IGF‑I receptor
Practical Outcomes
- MGF could be used to kick‑start muscle growth by increasing cell numbers, but it may also delay the cells from becoming mature muscle fibers. For biohackers, this means timing and dosing would be critical—perhaps using MGF early in a training cycle and switching to IGF‑I or other agents later for proper muscle formation. More human data are needed before safe protocols can be recommended.
Summary
The study shows that the IGF‑I Ec peptide (also called MGF) makes muscle precursor cells multiply more but stops them from fully maturing into muscle fibers, and it does this through a different receptor than regular IGF‑I. This helps explain why older people and those with muscle diseases lose muscle, because their MGF production is altered.
Abstract
The physiological function of a recently cloned splice variant of insulin-like growth factor-I (IGF-I; mechano growth factor (MGF)) was studied using an in vitro cell model. Unlike mature IGF-I, the distinct E domain of MGF inhibits terminal differentiation whilst increasing myoblast proliferation. Blocking the IGF-I receptor with a specific antibody indicated that the function of MGF E domain is mediated via a different receptor. The results provide a basis for localized tissue adaptation and helps explain why loss of muscle mass occurs in the elderly and in dystrophic muscle in which MGF production is markedly affected.
Study Information
pubmed
2002
2002-07-03T00:00:00.000Z
10.1016/s0014-5793(02)02918-6